UK

Biogen's Spinraza gets an early no-go from NICE
Biogen's Spinraza gets an early no-go from NICE
Biopharma Dive
Biogen
UK
NICE
Spinraza
SMA
spinal muscular atrophy
Flag link:
The UK's MHRA Grants Early Access to Anlylam's Patisiran
The UK's MHRA Grants Early Access to Anlylam's Patisiran
CP Wire
Alnylam
Patisiran
hATTR amyloidosis
UK
Flag link:
U.K. to offer Merck's Gardasil to boys after years of protests
U.K. to offer Merck's Gardasil to boys after years of protests
Fierce Pharma
UK
Merck
Gardasil
HPV
vaccines
Flag link:
AstraZeneca to stockpile drugs as Brexit 'safety net'
AstraZeneca to stockpile drugs as Brexit 'safety net'
Reuters
AstraZeneca
Brexit
UK
Europe
Flag link:
Vertex spars with UK's May over Orkambi pricing
Vertex spars with UK's May over Orkambi pricing
Biopharma Dive
Vertex Pharmaceuticals
UK
cystic fibrosis
innovation
drug pricing
Orkambi
Flag link:
Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest
Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest
Endpoints
Donald Trump
UK
Brexit
JNJ
GSK
Pharma CEOs
Alex Gorsky
Emma Walmsley
Flag link:
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Endpoints
Catalent
Juniper Pharmaceuticals
UK
M&A
drug development
Flag link:
Early access to Santhera’s DMD therapy Raxone extended in the UK
Early access to Santhera’s DMD therapy Raxone extended in the UK
Pharma Times
UK
Santhera
Raxone
Duchenne Muscular Dystrophy
Flag link:
Scientists set out to build an ultra-fast camera to capture effect of new cancer drug tech
Scientists set out to build an ultra-fast camera to capture effect of new cancer drug tech
Endpoints
UK
biotech
cancer
devices
Flag link:
Brexit Is Seen Costing Pharma Hundreds of Millions of Pounds
Brexit Is Seen Costing Pharma Hundreds of Millions of Pounds
Bloomberg
Brexit
UK
Europe
pharma industry
Flag link:
Beating Cancer With AI Or Achieving Brexit On Time: A Leadership Challenge For Theresa May
Beating Cancer With AI Or Achieving Brexit On Time: A Leadership Challenge For Theresa May
Forbes
artificial intelligence
cancer
Theresa May
UK
Brexit
Flag link:
Gates Foundation and U.K. pledge $50M to superbug treatment drive
Gates Foundation and U.K. pledge $50M to superbug treatment drive
Fierce Biotech
superbugs
antibiotic resistance
Bill Gates
Gates Foundation
UK
CARB-X
Flag link:
With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?
With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?
Forbes
Pfizer
Viagra
UK
OTC
VIAGRAconnect
erectile dysfunction
Flag link:
With U.S. brand sales deflating, Pfizer gears up for over-the-counter Viagra in U.K.
With U.S. brand sales deflating, Pfizer gears up for over-the-counter Viagra in U.K.
Fierce Pharma
Pfizer
UK
OTC
Viagra
erectile dysfunction
Flag link:
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Endpoints
Sarepta Therapeutics
golodirsen
Duchenne Muscular Dystrophy
UK
Flag link:
EMA frets drug shortages ahead of Brexit
EMA frets drug shortages ahead of Brexit
Biopharma Dive
EMA
Europe
UK
drug shortages
Brexit
Flag link:
Pharmaceutical industry needs ‘certainty’ on post-Brexit regulations, MPs told
Pharmaceutical industry needs ‘certainty’ on post-Brexit regulations, MPs told
Ludlow Advertiser, UK
pharma industry
UK
Brexit
regulatory
Flag link:
UK gives Pfizer world's first over-the-counter Viagra approval
UK gives Pfizer world's first over-the-counter Viagra approval
Yahoo/Reuters
Pfizer
OTC
Viagra
UK
erectile dysfunction
Flag link:
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts twin NICE recommendations
Fierce Pharma
Pfizer
Ibrance
Novartis
Kisqali
England
breast cancer
UK
NICE
Flag link:
Seqirus investing $52M, adding 100 jobs to U.K. flu vaccine site prompted by thoughts of pandemics
Seqirus investing $52M, adding 100 jobs to U.K. flu vaccine site prompted by thoughts of pandemics
Fierce Pharma
Seqirus
UK
flu vaccines
vaccines
drug manufacturing
Flag link:

Pages